CClinicalTrials.gg
RecruitingNCT06649500UAIUpdated Mar 19, 2025

Identify the Most Effective Rehabilitation Method Between a Treatment with a Sensorized Treadmill (Walker View) and a Treatment with Conventional Group Therapy in Balance Disorders and the Use of Artificial Intelligence to Identify Predictive Indices to Prevent Falls and Diagnose Promptly the Risk

An interventional study of Treadmill and conventional therapy in Balance Disorders, Rehabilitation and Falls, sponsored by Fondazione Policlinico Universitario Campus Bio-Medico. Recruiting at 1 site in Italy. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-03-19.

Sponsored by Fondazione Policlinico Universitario Campus Bio-Medico · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Dec 2024; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Falls in the elderly are one of the main sources of disability and hospitalization, with a significant impact on quality of life and social and healthcare costs. Falls represent a significant health concern for people over 60 years old. Numerous studies have shown that falls cause serious health consequences. Around 30% of people over the age of 60 experience a fall during the year.

According to the impact falls have, the investigators decided to analyze the effectiveness of training on a Walker View sensorized treadmill, with the possibility of exercises for coordination and balance, compared to training with a conventional group therapy, in order to understand the best training to reduce the risk of falling and observe the possible improvements in daily life activities.

So the study aims to identify the most effective rehabilitation method between a treatment with a sensorized treadmill (Walker View) and a conventional group therapy in balance disorders.

The study also aims to identify predictive indices, with the use of Artificial Intelligence, that can contribute to the prevention and diagnosis of balance disorders in a short time and prevent falls in the elderly.

02

Conditions studied

  • Balance Disorders
  • Rehabilitation
  • Falls
  • Falls Prevention
  • Artificial Intelligence (AI)
  • Elderly (people Aged 65 or More)
03

In context

Lead sponsor

Fondazione Policlinico Universitario Campus Bio-Medico is the lead sponsor of 29 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥ 65 years
  • Consent to participate in the study
  • Positive history of balance disorders
  • Absence of cognitive deficits (MMSE ≥ 24)
  • Tinetti \< 25

Exclusion criteria

Exclusion Criteria:

  • Clinical pictures associated with musculoskeletal, cardiovascular, cerebrovascular, neuro-psychic problems and post-surgical outcomes that make the planned evaluation tests unfeasible.
  • Inability to carry out a walking test.
  • History of more than one fall in the last six months.
  • Subjects who have not expressed informed consent to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
108 participants (estimated)

Study arms

  • Experimental
    Experimental Sensorized Treadmill

    Patients will carry out treatment with a sensorized treadmill, Walker View. This treadmill gives the possibility to patients to see their image reconstructed in a 3D mode in order to observe the bad aligments that increase the patients balance disorders. The feedback systems are necessary to give continuous stimulation to the patients. Each patients will carry out 18 treatment sessions and each session will last 30 minutes

    Other: Treadmill

  • Active comparator
    Conventional Therapy

    Patients in this arm will carry out treatment with a conventional group therapy, consisting in usual treatment according to current clinical practice. Each patient will undergo 18 sessions of conventional therapy based on group re-education.

    Other: conventional therapy

  • No intervention
    Clinical monitoring

    Patients in this arm will take part in the 'no intervention' part of the study and they will not carry out treatment. Patients will undergo only a clinical monitoring with an educational intervention, which does not elvove treatment or exercises, and they will continue to follow their daily habits.

Interventions

  • OtherTreadmill

    The Walker View system is a treadmill equipped with a loaded cell sensor belt and a 3D camera that allows you to detect every single angular movement of the subject. Furthermore, thanks to the two optics, a classic one for 2D shooting in high resolution, and a revolutionary one for infrared rays, it is possible to reconstruct the position of the subject in space in three-dimensional mode and in real time. The reflected image reconstructed by the system helps to improve movement through the \&#34;continuous feedback system\&#34; method.

  • Otherconventional therapy

    Conventional therapy intervention will follow the usual treatment according to current clinical practice. This treatment will be delivered to patients in a group session in order the balance disorders.

06

What researchers measure

Primary outcomes

  1. Change in Step Length of Gait Analysis

    The Gait Analysis is used to assess individuals with conditions that affect their ability to walk. It is a useful test for studying gait, thanks to instruments that measure the load on each limb and walking in general. It allows us to evaluate progresses at different time frames.

    Time frame: Baseline, 6 weeks, 10 weeks

Secondary outcomes

  1. Balance

    Balance will be assessed through the Tinetti Scale, a validated tool to measure balance skills, including risk of falls and walking in elderly subjects. Each item is given a score ranging from 0 to 2, where zero equals inability, 1 ability with aid or adaptation and 2 complete ability. A lower score indicates lower capabilities. A score \< or equal to 18 indicates high risk of falling, 19-24 indicates medium risk of falling, \> or equal to 25 low risk of falling.

    Time frame: Baseline, 6 weeks, 10 weeks

  2. Mobility

    Mobility is assessed through the Time Up and Go Test that measures the level of mobility and requires static and dynamic balancing skills to perform the test

    Time frame: Baseline, 6 weeks, 10 weeks

  3. Risk of falling

    Risk of falling is assessed through the Berg Scale used to assess balance and the risk of falling. 14 items will be evaluated, each item assigns a score from 0 to 4 (with 0 = unable to perform the task, 4 = able to perform the task within the times and conditions indicated). Scores below 20 points indicate the need for the patient to use a wheelchair or aids; scores between 21 and 45 suggest using an aid when walking; scores above 45 suggest patients are able to move safely without the need of aids.

    Time frame: Baseline, 6 weeks, 10 weeks

  4. Daily Living

    Daily Living is assessed with the Barthel Index for Activities of Daily Living. It is an ordinal scale which measures a persons ability to complete activities of daily living (ADL) and it assesses functional independence. The scale assigns one point for each independent function in order to obtain a total performance result that varies from 0 (complete dependence) to 6 (independence in all functions).

    Time frame: Baseline, 6 weeks, 10 weeks

  5. Instrumental Activites of Daily Living

    These activities will be assessed through the IADL scale and it respectively investigates the ability of elderly subjects to carry out fundamental functions of daily life. One point will be assigned for each independent function in order to obtain a total performance result that varies from 0 (complete dependence) to 8 (independence in all functions)

    Time frame: Baseline, 6 weeks, 10 weeks

  6. Muscle strength

    This will be assessed with the Motricity Index which aims to measure muscle strength and motor skills at the limb level.

    Time frame: Baseline, 6 weeks, 10 weeks

  7. Patient reported Quality of Life

    This will be assessed by the QoL scale SF-36. It measures 36 items in order to objectify to quantify health status and measure health-related quality of life. The aggregate scores for each domain range from 0 to 100, as a percentage, where the higher the score, the more favorable the health status.

    Time frame: Baseline, 6 weeks, 10 weeks

  8. Stability

    This outcome measure will be assessed with the stabilometric platform, which measures the average position of the body's centre of gravity and its small movements around that position.

    Time frame: Baseline, 6 weeks, 10 weeks

07

Study locations

1 of 1 sites recruiting
  • Policlinico Universitario Campus Bio Medico di Roma
    Rome, 00128, Italy
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06649500
Lead sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Responsible party
Federica Bressi (Professor, Fondazione Policlinico Universitario Campus Bio-Medico) — Principal investigator
First posted
Oct 18, 2024
Start date
Dec 4, 2024
Primary completion
May 2026 (estimated)
Completion
Jun 2026 (estimated)
Last update
Mar 19, 2025

Study contacts

Federica Bressi, MD
Contact
f.bressi@policlinicocampus.it
+39 0622541624

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion